-
RELATION NAME
-
2. Andes D.R. et al.: In vivo pharmacodynamic target investigation for micafungin against Candida albicans and C. glabrata in a neutropenic murine candidiasis model. Antimicrob. Agents Chemother., 52, 3497, 2008.
-
3. Arendrup M.C. et al.: European Committee for Antimicrobial Susceptibility Testing (EUCAST). Methods for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts. EUCAST definitive document EDef 7.2 Revision. March 2012.
-
4. Baran E., Dyląg M.: Echinokandyny - wielkocząsteczkowe lipopeptydy o aktywności przeciwgrzybiczej. Przegl. Dermatol., 93, 131, 2006.
-
5. Barry A.L. et al.: Quality control limits for broth microdilution susceptibility tests of ten antifungal agents. J. Clin. Microbiol., 38, 3457, 2000.
-
6. Bennett J.E., Izumikawa K., Marr K.A.: Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis. Antimicrob. Agents Chemother., 48, 1773, 2004.
-
RELATION NAME
-
8. Carter N.J., Keating G.M.: Micafungin: A review of its use in the prophylaxis and treatment of invasive Candida infections in pediatric patients. Paediatr Drugs., 11, 271, 2009.
-
RELATION NAME
-
10. Chion Ch., Groll A., Walsh T.: New drugs and novel targets for treatment of invasive fungal infections. Oncologist., 2, 120, 2000.